Biotech 2050 Podcast cover image

Biotech 2050 Podcast

Overcoming Capital Challenges in Biotech, Jak Knowles, President & CEO, Affini-T Therapeutics

Dec 13, 2023
Jak Knowles, President & CEO, Affini-T Therapeutics, shares insights on capital challenges in biotech, importance of key partners, early IP, experienced investors, and Affini-T's innovative approach to solid tumors using cell therapy and synthetic biology. Essential for biotech entrepreneurs.
26:10

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • Securing intellectual property early on and finding key partners are crucial for bootstrapped biotech companies.
  • Experienced investors and being one of the first investments out of a fund can greatly benefit biotech startups.

Deep dives

Jack Knowles' Background in Biotech

Jack Knowles, co-founder, president, and CEO of Affinity Therapeutics, discusses his background in biotech. He shares his journey from working at Sloan Kettering to prescribing cancer medicine at Stanford, and his decision to move into the biotech industry to make a greater impact on patients' lives.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner